Tseng, D., Moon, J., Bazhenova, L., Leighl, N. B., Borghaei, H., Dragnev, K. H., Baik, C. S., Langer, C. J., Neal, J. W., Gandara, D. R., Kelly, K., Gray, J. E., Herbst, R. S., Waqar, S. N., Reckamp, K. L., Redman, M. W. (2026). Immune-related adverse event severity and clinical outcomes with immune checkpoint inhibitor immunotherapy in participants with non–small cell lung cancer: Analysis of the lung MAP sub-studies S1400A, S1400I, S1400F, and S1800A.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.8572